The scientific community at the American Society for Mass Spectrometry (ASMS) 2026 conference, held from May 31 to June 4 in California, USA, recognized Professor Albert Heck of Utrecht University (The Netherlands) with the prestigious John B. Fenn Distinguished Contribution Award. This accolade celebrates Professor Heck’s pioneering advancements in biomolecular mass spectrometry (MS), particularly his foundational work in native MS and his innovative development of cross-linking MS, techniques that have profoundly reshaped our understanding of complex biological systems and accelerated drug discovery.
A Legacy of Innovation: The John B. Fenn Distinguished Contribution Award
The John B. Fenn Distinguished Contribution Award is one of the highest honors in the field of mass spectrometry, established to recognize individuals who have made significant, sustained contributions to the advancement of MS. Named after Nobel laureate John B. Fenn, whose groundbreaking work on electrospray ionization (ESI) revolutionized the analysis of large biomolecules, the award underscores the profound impact of scientific ingenuity on both fundamental research and practical applications. ASMS, the largest professional organization for mass spectrometry in North America, serves as a crucial forum for disseminating cutting-edge research and fostering collaboration. Professor Heck’s receipt of this award at the 74th annual conference highlights his pivotal role in extending the capabilities of MS to domains previously thought inaccessible, aligning perfectly with Fenn’s legacy of opening new frontiers in molecular analysis. The conference itself, a vibrant hub of innovation, showcased a plethora of new instruments and methodologies, further emphasizing the dynamic evolution of the field that Heck has so significantly influenced.
Demystifying Macromolecules: The Rise of Native Mass Spectrometry
For decades, the analysis of large, intact biological macromolecules by mass spectrometry remained a formidable challenge. The sheer size, structural complexity, and delicate nature of molecules like proteins, ribosomes, and viruses made their gas-phase transfer and accurate mass determination incredibly difficult. Professor Heck recounted the significant skepticism he encountered when he first ventured into this nascent field over two and a half decades ago. "There were only a handful of groups around the world trying to analyze huge macromolecules by MS," he explained. "Half of the people you approached would say, ‘why do you want to do this?’ And the other half would say, ‘that’s impossible, it’s never going to happen, or be useful.’"
Despite this initial resistance, Heck’s laboratory at Utrecht University embarked on a relentless quest to push the boundaries of MS technology. His pioneering efforts focused on developing specialized mass analyzers capable of handling the unique demands of large biomolecular complexes. This involved meticulous refinement of ion sources, vacuum systems, and detector technologies to maintain the integrity of these delicate structures during ionization and analysis. The award specifically recognized his instrumental contributions to enabling the analysis of colossal biological assemblies, including entire ribosomes and intact viral particles – entities far exceeding the typical size range amenable to conventional MS.
The popularization of native MS was a gradual process, spanning one to two decades. However, its utility became undeniably evident with the paradigm shift in the pharmaceutical industry. The emergence of biologics – therapeutic antibodies, gene delivery vectors like lipid nanoparticles and virus-like particles, and nucleic acid-based therapies such as mRNA and DNA plasmids – presented a new challenge. These modalities possess immense molecular masses that were previously unmeasurable with precision. Native MS provided the indispensable tool for their comprehensive characterization, enabling researchers to accurately determine their composition, assess purity, and monitor structural integrity. The ability to directly measure the intact mass of these complex therapeutics, rather than relying on indirect methods, has been a game-changer for quality control, process development, and understanding drug mechanisms. This direct evidence provided the irrefutable "why" and "how it can be done" that ultimately silenced the skeptics, paving the way for the field’s rapid expansion. The global biologics market, valued at over $400 billion in 2023, is projected to reach nearly $800 billion by 2030, underscoring the critical need for advanced analytical tools like native MS in this burgeoning sector.
Unraveling Nature’s Blueprints: Diverse Applications of Native MS
The power of native MS lies in its ability to provide unambiguous, quantitative data about molecular masses, a fundamental truth in biological analysis. "If you measure a mass, it doesn’t lie; if you detect it, it is there," Professor Heck asserted. This directness has proven invaluable in challenging and refining long-held "textbook views" of macromolecular composition, many of which were based on simplified models.
By carefully fragmenting large complexes within the mass spectrometer, native MS can reveal the intricate architecture of these assemblies, detailing their building blocks and the patterns of their subunit interactions. This capability has been instrumental in dissecting the assembly pathways of complex protein machines. Perhaps even more compelling is native MS’s unparalleled ability to detect subtle yet functionally significant variations in these complexes. Researchers can observe divergent forms – instances where a subunit might be missing, an additional component is present, or post-translational modifications (PTMs) alter the molecular landscape. Such heterogeneity is often difficult, if not impossible, to detect with other structural biology techniques, yet it holds crucial insights into cellular regulation, disease states, and adaptive responses.
Beyond well-known examples like ribosomes, which native MS has shown to exist in multiple distinct forms within a single cell, Heck’s lab and others have applied the technique to a wide array of biological systems. This includes dissecting the assembly and intricate working mechanisms of bacterial circadian clocks, shedding light on how organisms regulate their daily rhythms. It has also provided unprecedented detail into the initial steps of complement activation, a vital immune mechanism central to inflammation and host defense. The scope of native MS continues to broaden, extending beyond protein complexes to encompass the characterization of large RNA and DNA structures, promising to revolutionize nucleic acid research and gene therapy development.
From Specialized Art to Accessible Tool: The Maturation of Native MS
Early adoption of native MS was indeed an endeavor for specialists. It demanded exceptionally clean samples, often requiring bespoke modifications to commercial mass analyzers, and a considerable degree of expertise and intuition from the operator – what Professor Heck described as "a bit of an art." However, significant technological advancements and methodological refinements over the years have largely democratized the technique.
Modern native MS benefits from more robust and sensitive commercial mass analyzers that no longer require extensive customization. Sample preparation protocols have become vastly more efficient, reducing the required sample input – a critical advantage when working with precious biological materials. Furthermore, the integration of online, automated analysis systems has streamlined workflows, making the technique more accessible and reproducible. Consequently, native MS has transcended its academic origins to become a mainstream analytical tool, widely adopted across both academia and industry. In the biopharmaceutical sector, it is now routinely employed for high-throughput screening of drug candidates, comprehensive characterization of biologics, and stringent quality control applications, cementing its status as an indispensable technique in modern drug development pipelines.
Pioneering Proximity: The Evolution of Cross-linking Mass Spectrometry
Professor Heck’s career has been driven by a consistent ambition: to use mass spectrometry to achieve what was previously considered impossible. This ethos led him to make profound contributions to cross-linking mass spectrometry (XL-MS), a technique designed to map the spatial organization of proteins within complex biological environments. While the concept of "gluing" proteins together that are in close proximity existed prior to his involvement, Heck envisioned a far more ambitious application.
His "big dream" was to extend XL-MS beyond simple binary protein interactions, aiming to map protein networks within entire organelles or even whole cells. This would allow researchers to identify which proteins are functionally associated by virtue of their physical proximity within the living cell – a true in situ interactome. This vision was initially met with considerable skepticism. Critics argued that analyzing cross-linked peptides from an entire cell would generate an overwhelming amount of data, leading to insurmountable "dynamic range problems" and rendering existing software incapable of processing the information.
However, the unwavering determination of his postdoctoral researcher, Dr. Fan Liu (now a professor at the Leibniz-Forschungsinstitut für Molekulare Pharmakologie and Charité in Berlin, Germany), proved pivotal. "She just said, ‘let’s just try,’" Heck recalled. This resolve spurred a concerted effort to overcome the perceived bottlenecks. The team developed a suite of technical modifications, including novel cross-linking chemistries, advanced fragmentation schemes tailored for cross-linked peptides (such as electron transfer dissociation or ETD), and innovative computational software algorithms capable of handling the vast and complex datasets. Their breakthrough demonstrated that in situ or in cellulo cross-linking of whole cells was indeed feasible, mapping protein-protein interactions on an unprecedented scale.
This seminal work, though further refined by subsequent research over the past decade, was instrumental in "getting the field moving." It tackled the primary obstacles and proved the concept, transforming XL-MS into a powerful, high-throughput method for interactomics. Today, XL-MS is increasingly utilized to explore the intricate networks of protein interactions that govern cellular function, offering insights into signaling pathways, macromolecular assembly, and disease mechanisms.
Synergy in Structural Biology: XL-MS and Electron Microscopy
A particularly exciting aspect of modern XL-MS lies in its complementary relationship with other structural biology techniques, most notably electron microscopy (EM) and electron tomography (ET). Electron tomography, in particular, has emerged as a leading approach for visualizing cellular structures at high resolution. However, EM excels when analyzing rigid, well-ordered structures. Many biological systems, especially dynamic protein complexes involved in transient interactions, exhibit considerable flexibility and fluidity, making them challenging to resolve definitively with EM alone.
This is precisely where XL-MS provides a critical advantage. By capturing snapshots of protein proximities within these more flexible and fluid structures, XL-MS offers spatial constraints that can be integrated with lower-resolution EM data. This integrative approach allows researchers to build more comprehensive and accurate models of dynamic cellular machinery. As Professor Heck emphasized, "If you accumulate these data sets together, you get a more comprehensive view of the cell state." Furthermore, he posited that "flexible moving proteins are likely functionally more active than the more rigid ones," suggesting that XL-MS’s ability to probe these dynamic interactions is key to understanding the true functional state of a cell. This synergy between XL-MS and EM represents a powerful new paradigm in structural biology, providing an atomic-level window into the dynamic organization of life.
Navigating the Frontier: Advice for Aspiring Cross-linking MS Users
Despite its immense power, Professor Heck acknowledged that cross-linking MS remains a more complex technique than native MS, particularly for newcomers. The rapid growth of the field has led to a proliferation of different crosslinkers, fragmentation techniques, software packages, and database search strategies. This abundance, while indicative of innovation, can be overwhelming. "For a newbie, it can be hard to choose what to use," Heck stated, noting that both vendors and academic labs often champion their specific methods as superior. The field, he suggested, has not yet reached full maturity or standardization.
For those embarking on their journey with XL-MS, Professor Heck offered pragmatic advice: "start simple with the most popular crosslinkers." By beginning with well-established and widely used reagents, researchers can gain foundational experience, quickly identify the inherent limitations of these methods, and then make more informed decisions about which specialized crosslinkers or techniques might be necessary for their specific biological questions.
Crucially, he underscored the paramount importance of rigorous control experiments in XL-MS. The nature of chemical cross-linking means there is a non-trivial chance of generating false-positive data, arising from non-specific cross-linking events or other artifactual modifications. "Control experiments are even more important than usual," he stressed. While this caution is vital, Heck encouraged new researchers not to be deterred. With careful planning, a systematic approach, and a commitment to thorough validation, the rewards are substantial. "With some time and investment, you should be able to get very valuable data," he concluded, envisioning a future where XL-MS continues to unlock the secrets of cellular organization and function.
Heck’s Enduring Legacy and the Future of Proteomics
Professor Albert Heck’s receipt of the John B. Fenn Distinguished Contribution Award at ASMS 2026 is a testament to a career defined by audacious vision and tireless innovation. His work on native MS transformed the characterization of biologics, providing critical tools for the biopharmaceutical industry. Simultaneously, his pioneering efforts in cross-linking MS opened new avenues for understanding the spatial organization and dynamic interactions of proteins within their native cellular context.
Heck’s contributions extend beyond mere technical advancements; they have fostered new ways of thinking about biological complexity. By providing methods to accurately measure the mass of vast molecular machines and to map their intricate internal architectures, he has empowered generations of scientists to ask and answer questions that were once considered intractable. As mass spectrometry continues its rapid evolution, integrating with other "omics" technologies and pushing towards single-cell analysis, the foundational principles and innovative spirit championed by Professor Heck will undoubtedly continue to inspire and guide the quest to understand life at its most fundamental level.
